Insights Across the
Access Ecosystem

CMS’ proposed drug prior authorization reforms signal progress toward faster, more electronic processes. But for manufacturers, the bigger question is whether patient support programs are ready to reduce provider workflow friction and make access easier to navigate.

Modern patient support programs cannot rely on disconnected systems, manual handoffs, and fragmented reporting. Scalable hub models require connected infrastructure, real-time visibility, and workflows that support patients, providers, field teams, and manufacturers.

Pharmaceutical manufacturers are rethinking how access programs are designed, supported, and scaled. For years, pharmacy operations were often treated as a downstream execution step. Once the access strategy was defined, the pharmacy model followed. But today’s patient support environment is more complex. Manufacturers are balancing affordability pressure, specialty pharmacy coordination, hub model evolution, faster therapy initiation, and growing expectations for visibility

Business development decisions are too important to be separated from market access reality. As access dynamics become more complex, BD teams need earlier, faster, and more actionable insight into how the market may respond. Market access should not be treated as a downstream planning function. It should be part of the asset evaluation process from the beginning. Because the value of an asset is not only defined by what it can do clinically. It is also defined by whe

Many Patient Support Programs are designed around ideal processes rather than real-world execution. In this article, we explore why clinician- and operator-informed design creates more resilient PSPs — and how tech-enabled infrastructure like HealthPACER® supports workflows as they actually happen.

In 2026, Field Reimbursement Managers need more than static reports. They need real-time, territory-aware visibility that helps them remove access barriers earlier. Here’s why retrospective dashboards no longer support modern field strategy.

Real-world evidence has long relied on administrative claims datasets. But claims show utilization, not always clinical reasoning. Here’s why pharmaceutical organizations are increasingly adopting EMR-first evidence models to understand treatment decisions, access dynamics, and real-world care.

The first 90 days after launch reveal whether access strategy is performing in clinical reality. Claims data alone shows utilization — not intent. Here’s why EMR-first evidence is becoming essential for decision-grade post-launch validation across pharmaceutical organizations.

Patient Support Programs were once designed as contained environments.Intake came in. Benefits were verified. Prior authorizations were tracked. Financial support was coordinated. Reports were generated.Everything lived inside the hub.But as more manufacturers explore insourced and hybrid hub models, the infrastructure behind patient services is becoming far more complex.In today’s environment, access depends on connection.Prescribing systems evolve. Specialty pharmacy platfo

“Standard of care” sounds straightforward — but treatment patterns vary widely across payers, geographies, and health systems. When comparator assumptions don’t reflect real-world practice, value arguments can lose credibility. Here’s why comparator strategy deserves closer scrutiny.

Winning coverage doesn’t guarantee adoption. Access friction, from benefit design to provider workflow, can quietly undermine uptake after launch. Here’s how leading teams map and address breakdown points before performance drifts.

Free goods alone can’t sustain modern Patient Assistance Programs. Learn how tech-enabled, compliant PAP design supports scalability, transparency, and long-term access.

Field Reimbursement Managers need more than reports—they need real-time visibility. Learn how modern PSP design and HealthPACER® empower FRMs with actionable insight that drives smarter access strategy.

Winning coverage doesn’t guarantee real-world uptake. Many access strategies break after launch, when early signals fail to predict how products perform in practice. Here’s why coverage alone isn’t enough — and where teams should be looking next.

Contracting rarely follows the original script. As payer assumptions shift mid-negotiation, access teams need real-time insight to adapt quickly and protect leverage. Here’s how leading teams stay ahead.

Many patient support programs perform well at launch but struggle as volume grows. This post explores why scalability requires intentional design—covering capacity planning, automation thresholds, and workflow elasticity as core principles for long-term PSP success.

As contracting season ramps up, payers are testing subscription pilots, outcomes triggers, and hybrid models alongside traditional rebates. Here’s what’s emerging — and how manufacturers should prepare.

“Visibility” means something different depending on who’s looking. Brands, FRMs, patient services teams, and compliance leaders all rely on visibility—but not the same kind. This post explores why patient support programs must deliver role-specific views without duplicative reporting to truly support access, accountability, and performance.

Insight alone no longer drives access success. Learn how leading organizations activate insight across HEOR, Medical, and Commercial to move faster, stay aligned, and support real-world decision-making.

Fragmented intake slows access, increases rework, and strains patient services teams. Learn how unified intake and case orchestration through HealthPACER® improve continuity and reduce delays.